INNOVATIVE ACQUISITIONS CORP

Profile

Company Names

INNOVATIVE ACQUISITIONS CORP
PUMA BIOTECHNOLOGY, INC.

Addresses

10940 WILSHIRE BLVD., SUITE 600, LOS ANGELES, CA 90024

12 GEORGIAN DRIVE, ATTN FARAAZ SIDDIQI, CUMBERLAND, RI 02864

Phone Numbers

401 334 3242
(310) 443-4150

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$75,000,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2011-11-18 
$4,999,751.00 
$4,999,751.00 
$0.00 
Equity 
1
2011-10-04 
$70,000,249.00 
$70,000,249.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALAN 
H. 
AUERBACH 
EXECUTIVE OFFICER, DIRECTOR
INNOVATIVE ACQUISITIONS CORP   |  PUMA BIOTECHNOLOGY, INC.   |  PUMA BIOTECHNOLOGY, INC.
CHARLES 
R. 
EYLER 
EXECUTIVE OFFICER
INNOVATIVE ACQUISITIONS CORP   |  PUMA BIOTECHNOLOGY, INC.   |  PUMA BIOTECHNOLOGY, INC.
THOMAS 
R. 
MALLEY 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  INNOVATIVE ACQUISITIONS CORP   |  PUMA BIOTECHNOLOGY, INC.   |  PUMA BIOTECHNOLOGY, INC.
RICHARD 
 
PHILLIPS, M.D. 
EXECUTIVE OFFICER
PUMA BIOTECHNOLOGY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-12-01
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-11-18 
2011-10-12
D/A
Link
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2011-10-04 
2011-10-04
D
Link
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2011-10-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK SWANN LLC
39011
NONE
NONE
NATIONAL SECURITIES CORPORATION
7569